Skyrizi 00074-4059-71

Generic: Risankizumab-Rzaa

Package NDC

00074-4059-71

Manufacturer: Abbvie Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: June 12, 2026
Listing Expires: December 31, 2027
Application: BLA761105

Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Risankizumab	55 mg/.37mL

Drug Class

Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]

Selected Package

00074-4059-71Selected

1 SYRINGE, GLASS in 1 CARTON (0074-4059-71) / .37 mL in 1 SYRINGE, GLASS

Other packages for this product(1)

00074-4059-01

1 SYRINGE, GLASS in 1 CARTON (0074-4059-01) / .37 mL in 1 SYRINGE, GLASS

View →